Akoya Biosciences Inc (AKYA) USD0.00001

Sell:$2.67Buy:$2.68$0.06 (2.29%)

NASDAQ:0.50%
Prices delayed by at least 15 minutes
Sell:$2.67
Buy:$2.68
Change:$0.06 (2.29%)
Prices delayed by at least 15 minutes
Sell:$2.67
Buy:$2.68
Change:$0.06 (2.29%)
Prices delayed by at least 15 minutes

Company Information

About this company

Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research, and diagnostics. It offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, and tissue microarrays (TMAs).

Key people

Brian Mckelligon
President, Chief Executive Officer, Director
Johnny Ek
Chief Financial Officer
Jennifer Kamocsay
General Counsel
Niro Ramachandran
Chief Business Officer
Scott Mendel
Independent Chairman of the Board
Thomas A. Raffin
Director
Myla P. Lai-Goldman
Independent Director
Thomas P. Schnettler
Independent Director
Robert G. Shepler
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US00974H1041
  • Market cap
    $135.83m
  • Employees
    330
  • Shares in issue
    49.57m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.